Stifel Maintains Buy on Boston Scientific, Lowers Price Target to $85

Benzinga Newsdesk www.benzinga.com Negative 58.3%

Neg 58.3% Neu 0% Pos 0%

Stifel analyst Rick Wise maintains Boston Scientific (NYSE:BSX) with a Buy and lowers the price target from $90 to $85.

Comments

No comments yet. Be the first!